Impact Venture Capital

Jack Crawford has spent nearly two decades building Sacramento’s startup ecosystem, founding a regional venture firm, hosting ImpacTV interviews, and creating a Corporate Network to connect enterprises with early-stage companies.

Gary Hooper is a Venture Partner at Impact Venture Capital with over four decades of experience in the biotechnology industry. He has held executive positions including CEO roles at Pharmetrix, Pharma Patch, Ciblex Corporation, and VerdiChrys Technology, as well as senior business development roles at Genentech, Cygnus, Genencor International, and other biotechnology firms. His background spans drug delivery, therapeutic development, and metabolic engineering, with involvement in multiple company acquisitions, IPOs, and strategic partnerships.

John Finegan is founder and board chair of Beck Ag, Inc., which provides customer relationship management, data analytics, and go-to-market solutions to food and agribusiness clients. The company offers services spanning master data management, predictive analytics, omnichannel sales and marketing, point-of-sale data collection, and loyalty program administration. Beck Ag also delivers agronomic data collection and management services to support clients' commercial strategy development.

Karen Crawford is a final-year JD candidate at University of the Pacific, McGeorge School of Law, concentrating in intellectual property law. She brings two decades of experience in venture capital, corporate development, and startup leadership, including prior roles as a VC investment analyst and co-founder of a consumer electronics company. Crawford holds an MBA and Master of Taxation, serves as Vice President of the McGeorge Intellectual Property Student Association, and is seeking an IP externship for 2026 with focus on trademark clearance, registration, and transactional work.

Patrick Bumpus is a Venture Investor and Vice President of Corporate Intelligence Programs at CIVC, where he has worked for over nine years. He focuses on capital formation, corporate innovation programs, and portfolio support, with experience collaborating with corporate venture capital teams at Fortune 500 companies. His expertise spans project management, alternative investments, and board leadership, with sector specialization in AI infrastructure, digital health, and consumer products.